The Australian wheatbelt is divided into three main growing regions: the North (New South Wales and Queensland), the South (Victoria, South Australia and Tasmania), and the West (Western Australia). Using wheat yield data from the 2015–2022 multi-environmental trials (METs) conducted by the National Variety Trials (NVT), this study examines genotype-by-environment interactions (G×E) and trialling efficiencies, within and across regions. The North had the highest mean yield (390 gm-2) and the largest proportion of phenotypic variance explained by G×E (64%), while the West had the lowest yield (355 gm-2) and the lowest G×E contribution (44%). Despite regional differences, yield gains were approximately 1.4 gm-2 per year (or ∼ 0.5% annually) across all regions. The West also showed the highest repeatability (0.85 ± 0.02) and the lowest least significance difference (5% LSD, 22 gm-2 ± 1 gm-2) for a benchmark five-year MET, compared to the South (0.70 ± 0.04, 35 ± 1.4 gm-2) and the North (0.59 ± 0.05, 35 ± 1.4 gm-2). Modelling results were consistent across regions and indicated that 2 years of testing at 20 sites per year delivered efficiencies that could not be improved very much further.
No takes yet. Share an insight, caveat, or question.
Arief et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: